Skip to main content
. 2018 Apr 7;24(13):1410–1418. doi: 10.3748/wjg.v24.i13.1410

Figure 2.

Figure 2

HLA-profile of the study population (n = 34) investigating HLA-A1, -B8, -DR3, and -DR4 status (A), and antibody-profile of the study population (n = 52) demonstrating positivity for ANA-, AMA-, SMA-, SLA-, ANCA-, and LKM-titers (B). ANA: Anti-nuclear; SMA: Anti-smooth muscle; LKM: Anti-liver kidney microsomal.